| Trussville Health & Rehabilitation Center | |
| 119 Watterson Parkway, Trussville, Alabama 35173 | |
| (205) 655-3226 | |
| Name | Trussville Health & Rehabilitation Center |
|---|---|
| Location | 119 Watterson Parkway, Trussville, Alabama |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 125 |
| Occupancy Rate | 70.96% |
| Medicare ID (CCN) | 015467 |
| Legal Business Name | Prohealth Ltc-trussville Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1366137044 |
| Organization Name | CAVALIER HEALTHCARE OF TRUSSVILLE, LLC |
| Address | 119 Watterson Pkwy, Trussville, AL 35173 |
| Phone Number | 205-655-3226 |
News Archive
Two studies to be presented today (Sunday) at the 3rd ESTRO Forum in Barcelona, Spain, show that increasing the dose of radiotherapy given to children with an intracranial ependymoma, a form of cancer of the central nervous system, can significantly improve their survival.
USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 medical device, announces that HIFU with the Sonablate is available to prostate cancer patients for the first time in Brazil at Hospital Nossa Senhora das Gracas in Curitiba, capital city of the state of Parana in southern Brazil.
Results released today from a landmark national survey of dermatologists and consumers unveiled that there is a major gap between what dermatologists recommend and what Americans actually do when it comes to sun-safe behavior. This gap further highlights the need for continued education to reverse the skin cancer epidemic in the United States.
For many patients, participating in gene therapy clinical trials isn't an option because their immune system recognizes and fights the helpful virus used for treatment.
› Verified 9 days ago
| NPI Number | 1497117279 |
| Organization Name | PROHEALTH LTC-TRUSSVILLE LLC |
| Doing Business As | TRUSSVILLE HEALTH & REHAB CENTER |
| Address | 119 Watterson Pkwy, Trussville, AL 35173 |
| Phone Number | 205-655-3226 |
News Archive
Two studies to be presented today (Sunday) at the 3rd ESTRO Forum in Barcelona, Spain, show that increasing the dose of radiotherapy given to children with an intracranial ependymoma, a form of cancer of the central nervous system, can significantly improve their survival.
USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 medical device, announces that HIFU with the Sonablate is available to prostate cancer patients for the first time in Brazil at Hospital Nossa Senhora das Gracas in Curitiba, capital city of the state of Parana in southern Brazil.
Results released today from a landmark national survey of dermatologists and consumers unveiled that there is a major gap between what dermatologists recommend and what Americans actually do when it comes to sun-safe behavior. This gap further highlights the need for continued education to reverse the skin cancer epidemic in the United States.
For many patients, participating in gene therapy clinical trials isn't an option because their immune system recognizes and fights the helpful virus used for treatment.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Two studies to be presented today (Sunday) at the 3rd ESTRO Forum in Barcelona, Spain, show that increasing the dose of radiotherapy given to children with an intracranial ependymoma, a form of cancer of the central nervous system, can significantly improve their survival.
USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 medical device, announces that HIFU with the Sonablate is available to prostate cancer patients for the first time in Brazil at Hospital Nossa Senhora das Gracas in Curitiba, capital city of the state of Parana in southern Brazil.
Results released today from a landmark national survey of dermatologists and consumers unveiled that there is a major gap between what dermatologists recommend and what Americans actually do when it comes to sun-safe behavior. This gap further highlights the need for continued education to reverse the skin cancer epidemic in the United States.
For many patients, participating in gene therapy clinical trials isn't an option because their immune system recognizes and fights the helpful virus used for treatment.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $32266 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 4.96 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.66 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 47.62 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.86 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.16 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.49 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.71 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.31 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 12.53 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 18.47 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.71 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 78.47 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 100 | 82.93 |
News Archive
Two studies to be presented today (Sunday) at the 3rd ESTRO Forum in Barcelona, Spain, show that increasing the dose of radiotherapy given to children with an intracranial ependymoma, a form of cancer of the central nervous system, can significantly improve their survival.
USHIFU LLC, a world leader in minimally invasive high intensity focused ultrasound technologies and manufacturer of the Sonablate 500 medical device, announces that HIFU with the Sonablate is available to prostate cancer patients for the first time in Brazil at Hospital Nossa Senhora das Gracas in Curitiba, capital city of the state of Parana in southern Brazil.
Results released today from a landmark national survey of dermatologists and consumers unveiled that there is a major gap between what dermatologists recommend and what Americans actually do when it comes to sun-safe behavior. This gap further highlights the need for continued education to reverse the skin cancer epidemic in the United States.
For many patients, participating in gene therapy clinical trials isn't an option because their immune system recognizes and fights the helpful virus used for treatment.
› Verified 9 days ago
Trussville Health & Rehabilitation Center Location: 119 Watterson Parkway, Trussville, Alabama 35173 Phone: (205) 655-3226 |